Calibr receives grant from Gates Foundation to develop an Integrated Drug Discovery Platform for Diseases of the Developing World - 21 News Now, More Local News for Youngstown, Ohio -

Calibr receives grant from Gates Foundation to develop an Integrated Drug Discovery Platform for Diseases of the Developing World

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE The California Institute for Biomedical Research

LA JOLLA, Calif., May 12, 2014 /PRNewswire-USNewswire/ -- The California Institute for Biomedical Research (Calibr) has received a grant from the Bill & Melinda Gates Foundation to develop an Integrated Drug Discovery Platform for Diseases of the Developing World (IDDP). The goal will be to identify innovative new therapeutics for the treatment of diseases of the developing world. The program will leverage ongoing research efforts and infrastructure at Calibr, as well as draw upon expertise in academia and industry by establishing collaborations. The grant provides support for multiple projects at various stages of preclinical development – from high-throughput screens to IND-enabling studies.  

Calibr's vision is to accelerate the translation of innovative biomedical research into new medicines that address unmet global health needs.  The program will comprise a diverse portfolio of projects in priority research areas, namely tuberculosis, helminth infections, diarrheal disease, and both pathogen- and vector-based approaches to malaria. Dynamic resourcing within the program will drive the most promising projects toward the clinic while continuing to identify additional discovery opportunities, generating a renewable pipeline of new therapies for neglected diseases.  

"We're delighted to work with the Gates Foundation on these important problems," said Dr. Peter Schultz, the Institute Director and founder of Calibr. "Calibr brings significant experience in both drug discovery and basic biomedical research to the challenges of discovering new medicines for the complex diseases of the developing world."

About Calibr: Calibr is an independent non-profit institute (established in 2012) with the goal of accelerating the translation of basic biomedical research to innovative new medicines that address major health challenges. Calibr is based on a collaborative model that matches its preclinical drug discovery infrastructure, platforms, and know-how with the deep expertise of the world's leading disease biology labs. Calibr has established relationships with leading academic labs, the pharmaceutical and biotechnology industry, as well as several foundations to build a diverse portfolio of projects and advance them toward the clinic. Calibr is led by Peter G. Schultz, Ph.D., a world-renowned chemist and biotechnology entrepreneur. Located in La Jolla, CA, Calibr has more than 80 scientists and staff in newly built labs located in close proximity to The Scripps Research Institute, The Salk Institute, and UC San Diego.

Contact:
The California Institute for Biomedical Research (Calibr)
Matt Tremblay, Ph.D.
Executive Director of Operations
T: +1-858-242-1005
mtremblay@calibr.org

©2012 PR Newswire. All Rights Reserved.

  • More From wfmj.comMore>>

  • Man charged for urinating on Modell's grave

    Man charged for urinating on Modell's grave

    Tuesday, July 29 2014 9:58 PM EDT2014-07-30 01:58:59 GMT
    Baltimore County authorities say they will charge a man with disorderly conduct in a cemetery for allegedly urinating on the gravesite of former Baltimore Ravens owner Art Modell.More >>
    Baltimore County authorities say they will charge a man with disorderly conduct in a cemetery for allegedly urinating on the gravesite of former Baltimore Ravens owner Art Modell.
    More >>
  • Senate passes highway bill, sends it back to House

    Senate passes highway bill, sends it back to House

    Tuesday, July 29 2014 8:47 PM EDT2014-07-30 00:47:27 GMT
    The Senate is scheduled to take up legislation Tuesday to keep federal highway money flowing to states, with just three days left before the government plans to start slowing down payments.More >>
    The Senate voted Tuesday to keep federal highway money flowing to the states into December but only after rejecting the House's reliance on what lawmakers called a funding "gimmick" and moving to force a post-election...More >>
  • 1 of 2 Ohio plane crash victims not yet identified

    1 of 2 Ohio plane crash victims not yet identified

    Monday, July 28 2014 9:48 PM EDT2014-07-29 01:48:43 GMT
    FINDLAY, Ohio (AP) - Authorities in northwest Ohio are still trying to identify one of two people killed in a weekend plane crash. One of the victims in the crash near Findlay was the CEO of an Ohio manufacturing company. A coroner was trying to identify the remains of a woman killed in the crash, but the Hancock County Sheriff's Office says DNA testing may be needed. Deputies say Ralf Bronnenmeier, CEO of Grob Systems in Bluffton, was piloting the single-engine plane that crashed early Sund...More >>
    FINDLAY, Ohio (AP) - Authorities in northwest Ohio are still trying to identify one of two people killed in a weekend plane crash. One of the victims in the crash near Findlay was the CEO of an Ohio manufacturing company. A coroner was trying to identify the remains of a woman killed in the crash, but the Hancock County Sheriff's Office says DNA testing may be needed. Deputies say Ralf Bronnenmeier, CEO of Grob Systems in Bluffton, was piloting the single-engine plane that crashed early Sund...More >>
Powered by WorldNow
All content © Copyright 2000 - 2014 Worldnow and WFMJ. All Rights Reserved. For more information on this site, please read our Privacy Policy and Terms